| Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial R Al-Lamee, D Thompson, HM Dehbi, S Sen, K Tang, J Davies, T Keeble, ... The Lancet 391 (10115), 31-40, 2018 | 1027 | 2018 |
| Use of the instantaneous wave-free ratio or fractional flow reserve in PCI JE Davies, S Sen, HM Dehbi, R Al-Lamee, R Petraco, SS Nijjer, R Bhindi, ... New England Journal of Medicine 376 (19), 1824-1834, 2017 | 932 | 2017 |
| Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept … DE Kandzari, M Böhm, F Mahfoud, RR Townsend, MA Weber, S Pocock, ... The Lancet 391 (10137), 2346-2355, 2018 | 782 | 2018 |
| Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled … RR Townsend, F Mahfoud, DE Kandzari, K Kario, S Pocock, MA Weber, ... The Lancet 390 (10108), 2160-2170, 2017 | 739 | 2017 |
| Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, J Davies, ... The Lancet 391 (10137), 2335-2345, 2018 | 664 | 2018 |
| A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial VF Tapson, K Sterling, N Jones, M Elder, U Tripathy, J Brower, ... JACC: Cardiovascular Interventions 11 (14), 1401-1410, 2018 | 369 | 2018 |
| Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial M Böhm, K Kario, DE Kandzari, F Mahfoud, MA Weber, RE Schmieder, ... The Lancet 395 (10234), 1444-1451, 2020 | 342 | 2020 |
| Tissue Doppler E/E′ ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy ASP Sharp, RJ Tapp, SAMG Thom, DP Francis, AD Hughes, AV Stanton, ... European heart journal 31 (6), 747-752, 2010 | 261 | 2010 |
| Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly, T Levy, LC Rump, ... The Lancet 397 (10293), 2476-2486, 2021 | 227 | 2021 |
| Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 204 | 2019 |
| Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary intervention: the DEFINE PCI study A Jeremias, JE Davies, A Maehara, M Matsumura, J Schneider, K Tang, ... JACC: Cardiovascular Interventions 12 (20), 1991-2001, 2019 | 175 | 2019 |
| Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial F Mahfoud, DE Kandzari, K Kario, RR Townsend, MA Weber, ... The Lancet 399 (10333), 1401-1410, 2022 | 146 | 2022 |
| Six-month results of treatment-blinded medication titration for hypertension control after randomization to endovascular ultrasound renal denervation or a sham procedure in the … M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, MD Lobo, ... Circulation 139 (22), 2542-2553, 2019 | 142 | 2019 |
| Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial M Bohm, K Kario, DE Kandzari, F Mahfoud, MA Weber, RE Schmieder, ... Lancet 395 (10234), 1444-1451, 2020 | 135 | 2020 |
| A new technique for vascular access management in transcatheter aortic valve implantation ASP Sharp, I Michev, F Maisano, M Taramasso, C Godino, A Latib, ... Catheterization and Cardiovascular Interventions 75 (5), 784-793, 2010 | 134 | 2010 |
| Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function PS Wild, JF Felix, A Schillert, A Teumer, MH Chen, MJG Leening, ... The Journal of clinical investigation 127 (5), 1798-1812, 2017 | 123 | 2017 |
| Safety of the deferral of coronary revascularization on the basis of instantaneous wave-free ratio and fractional flow reserve measurements in stable coronary artery disease … J Escaned, N Ryan, H Mejía-Rentería, CM Cook, HM Dehbi, ... JACC: Cardiovascular Interventions 11 (15), 1437-1449, 2018 | 122 | 2018 |
| Pre-angioplasty instantaneous wave-free ratio pullback predicts hemodynamic outcome in humans with coronary artery disease: primary results of the international multicenter iFR … Y Kikuta, CM Cook, ASP Sharp, P Salinas, Y Kawase, Y Shiono, ... JACC: Cardiovascular interventions 11 (8), 757-767, 2018 | 116 | 2018 |
| SPYRAL HTN-OFF MED trial investigators*. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN … RR Townsend, F Mahfoud, DE Kandzari, K Kario, S Pocock, MA Weber, ... Lancet 390 (10108), 2160-2170, 2017 | 107 | 2017 |
| Fractional flow reserve and instantaneous wave-free ratio as predictors of the placebo-controlled response to percutaneous coronary intervention in stable single-vessel … R Al-Lamee, JP Howard, MJ Shun-Shin, D Thompson, HM Dehbi, S Sen, ... Circulation 138 (17), 1780-1792, 2018 | 105 | 2018 |
